EXCOR Pediatric Ventricular Assist Device
Berlin Heart, Inc. · Decision date Jun 6, 2017
What did the FDA approve?
FDA records P160035 as an original PMA application. The recorded decision is approval, dated Jun 6, 2017.
FDA approval order statement
Approval for the EXCOR Pediatric Ventricular Assist Device (referred to as EXCOR Pediatric) is intended to provide mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients. Pediatric candidates with severe isolated left ventricular or biventricular dysfunction who are candidates for cardiac transplant and require circulatory support may be treated using the EXCOR Pediatric.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 6, 2017
Regulatory record facts
- Identifier
- P160035
- Regulatory pathway
- Premarket approval application
- Applicant
- Berlin Heart, Inc.
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Jun 6, 2017
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
- Applicant
- Berlin Heart, Inc.
- Product code
- DSQ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P160035 received
Application receipt date recorded by FDA.
P160035 · FDA decision
APPR
P160035/S058 · Related supplement
EXCOR Pediatric Ventricular Assist Device
P160035/S057 · Related supplement
EXCOR Pediatric Ventricular Assist Device
P160035/S056 · Related supplement
EXCOR Pediatric VAD
P160035/S060 · Related supplement
EXCOR Pediatric Ventricular Assist Device
P160035/S061 · Related supplement
EXCOR Pediatric VAD
P160035/S054 · Related supplement
EXCOR Pediatric Ventricular Assist Device
Timeline entries are records held by MedtechLedger for P160035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S058 | Berlin Heart, Inc. | PMA supplement | Sep 1, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S057 | Berlin Heart, Inc. | PMA supplement | Oct 1, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S033 | Abbott | PMA supplement | Oct 2, 2026 | FDA |
HeartMate II LVASP060040/S128 | ABBOTT MEDICAL | PMA supplement | Oct 1, 2026 | FDA |
HeartMate 3 LVASP160054/S135 | ABBOTT MEDICAL | PMA supplement | Oct 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Berlin Heart, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9391 Grogan'S Mill Rd., Suite A-6, The Woodlands, TX, 77380
Sources and methodology
- Original FDA record: P160035
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





